Regulatory

Latest News

us capitol building
The Increasing Access to Biosimilars Act of 2023 Introduced to Congress

March 29th 2023

The Increasing Access to Biosimilars Act of 2023 (HR 1352), a bill that would direct HHS to establish a demonstration project within Medicare that would establish a shared savings model for biosimilars, was introduced to the House of Representatives.

canada flag
Canadian Province Newfoundland and Labrador Adds Biosimilar Switching Policy

March 28th 2023

syringe over pile of pills
Uptake Barriers Will Deter Future Competitors From Investing in Biosimilars, Julie Reed Warns

March 21st 2023

globe showing china and a stethoscope
Researchers Recommend Improvements for China’s Biosimilar Regulatory Policies

March 16th 2023

globe
Biorationality: A Dr Sarfaraz Niazi Column—A New Perspective on Biosimilars' Role Within Big Pharma

March 13th 2023

Video Interviews
Podcasts
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
canadian flag on a mountain
CfB podcast banner
CfB podcast banner
Cfb podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.